CLOV vs GANX · rev $1.37B vs rev $55.2K
Clover Health Investments Corp (CLOV) versus Gain Therapeutics Inc (GANX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Gain Therapeutics Inc (GANX) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported GANX revenue for 2023-12-31 was $55.2K. Net income was -$22.3M. Revenue was down 60.6% from 2022-12-31 to 2023-12-31. GANX currently screens at market cap $53.0M.
CLOV currently screens at market cap $1.55B. GANX currently screens at market cap $53.0M.
Not investment advice. Open the CLOV and GANX stock pages for the full models.
Not investment advice.